On June 12, 2026, the U.S. Meals and Drug Administration cleared the primary over-the-counter steady glucose monitor (CGM) for youngsters, the Dexcom Inc. Stelo Glucose Biosensor System, an built-in CGM indicated for individuals two years of age and older who don’t use insulin. That is the primary time within the historical past of pediatric diabetes care {that a} glucose monitoring expertise for youngsters doesn’t require a doctor’s prescription.
The sensible consequence is important: dad and mom can now buy a wearable blood sugar monitoring machine for his or her youngster immediately from a pharmacy, grocery retailer, or on-line retailer, with out scheduling a clinic appointment, ready for a prescription renewal, or acquiring prior authorization from an insurance coverage plan.
Why This Issues
A CDC report discovered an estimated 8.4 million adolescents aged 12 to 17 years — roughly 32.7% — have glucose ranges within the prediabetes vary. Prediabetes in youngsters, if unaddressed, considerably raises the chance of development to Kind 2 diabetes, heart problems, and metabolic issues that compound over a lifetime.
For the rising inhabitants of youngsters managing Kind 2 diabetes with oral medicine, real-time glucose information supplies data that may immediately enhance day by day administration choices. Till now, all CGM units for youngsters required a prescription, making a cascading entry barrier: no prescription and not using a clinic go to, no clinic go to with out insurance coverage or transportation, no prior authorization with out administrative follow-through. The OTC clearance removes the primary hyperlink in that chain.
What We Know So Far
The FDA beforehand cleared the Stelo Glucose Biosensor System over-the-counter for people 18 years and older in March 2024. The June 12, 2026, clearance extends the indication to youngsters ages 2 and older who don’t use insulin.
The expertise consists of a wearable glucose sensor paired with a smartphone utility that shows glucose values and tendencies each quarter-hour. Sensors last as long as 15 days, although the Pharmacy Instances notes that sensors could not final the total 15 days in some youthful youngsters. Dexcom at the moment sells Stelo sensors in packages of two for roughly $89 to $99 per thirty days.
The FDA included real-world proof and prior medical research information from each pediatric and grownup customers to help efficiency expectations, enabling clearance and not using a devoted pediatric trial.
The product is indicated for youngsters, together with these with diabetes who obtain oral medicine to handle their situation, and youngsters who need to perceive how weight-reduction plan, train, and different life-style adjustments have an effect on their glucose ranges.
The FDA emphasised that the Stelo system isn’t designed for youngsters who use insulin, those that expertise problematic hypoglycemia, or sufferers on dialysis. For insulin-dependent youngsters, prescription CGMs with hypoglycemia alerts stay the suitable medical device.
Who Advantages Most — and Who Does Not
The OTC Stelo CGM is particularly designed for youngsters who:
Have been recognized with prediabetes
Are managing Kind 2 diabetes with oral medicine (not insulin)
Do not need a historical past of extreme low blood sugar occasions
Or whose dad and mom merely need to perceive how meals, exercise, and day by day habits have an effect on their kid’s blood sugar
The machine isn’t acceptable for:
Kids with Kind 1 diabetes (who require insulin and alerts for hypoglycemia)
Kids on insulin of any form
Kids on dialysis
Kids with a historical past of problematic low blood sugar occasions
Dad and mom ought to seek the advice of a pediatrician or pediatric endocrinologist earlier than utilizing a CGM in any youngster with a confirmed diabetes prognosis, particularly if the administration plan contains drugs.
What Docs and Consultants Say
“Kids deserve entry to the perfect instruments accessible to handle their well being,” mentioned Michelle Tarver, M.D., Ph.D., Director of the FDA’s Heart for Units and Radiological Well being. “At the moment’s clearance displays the FDA’s dedication to fostering innovation for pediatric sufferers and supporting the protected and efficient use of medical units the place youngsters reside, study, and play.”
The American Pharmacists Affiliation has launched a CGM certificates coaching program to assist pharmacists counsel sufferers on the level of sale, making group pharmacists a vital level of schooling for households buying the machine and not using a medical go to.
What the Proof Reveals — and What It Does Not
MedicalDaily Proof Test
Machine kind: Built-in Steady Glucose Monitor (iCGM)
Regulatory pathway: 510(ok) clearance (enlargement of current grownup machine indication)
Information used: Actual-world proof mixed with prior medical research information from grownup and pediatric customers
What it discovered: Machine performs reliably throughout the sensor put on interval in each grownup and pediatric populations
What it doesn’t show: The machine doesn’t detect or alert for hypoglycemia — it isn’t a therapeutic machine and doesn’t exchange medical judgment for insulin-using sufferers
Reported unintended effects: Delicate pores and skin irritation, localized an infection, ache or discomfort on the sensor website
What readers ought to know: This machine is a monitoring device — not a therapy
Signs and Patterns to Watch For
Dad and mom utilizing the OTC Stelo CGM may even see glucose patterns that immediate follow-up care. Patterns that warrant a dialog with a pediatrician embrace:
Persistently excessive glucose ranges after meals (above 140 mg/dL two hours after consuming)
Persistent elevated fasting glucose ranges (above 100 mg/dL)
Large swings in glucose throughout the day
Low glucose ranges in a baby who doesn’t use insulin
None of those patterns are an emergency on their very own, however they’re alerts to carry to a clinician. Don’t regulate any kid’s weight-reduction plan, train, or drugs primarily based solely on CGM information with out medical steering.
What You Can Do Now
Ask your pediatrician whether or not this machine is suitable to your youngster. The OTC CGM isn’t the correct device for each youngster. A clinician might help assess whether or not your kid’s glucose administration plan warrants real-time monitoring.
Test the indication fastidiously. Verify your youngster doesn’t use insulin earlier than buying the OTC Stelo machine. Insulin-using youngsters want a prescription CGM.
Buy via licensed pharmacies. The Stelo Glucose Biosensor System is offered at main pharmacy chains and thru approved on-line retailers.
Obtain the companion app earlier than the sensor goes on. The machine requires a smartphone to show information. Make sure the app is ready up and related earlier than activating the sensor.
Deliver CGM information to clinic visits. Share glucose development information together with your kid’s care crew to place readings in medical context.
Price and Entry: What Households Ought to Know
Dexcom sells Stelo sensors in packages of two at roughly $89 to $99 per thirty days. As an OTC product, it might not be lined by insurance coverage below the identical phrases as a prescribed machine, although households might be able to submit for reimbursement below a versatile spending account (FSA) or well being financial savings account (HSA). Medicaid protection for OTC medical units varies by state. Dexcom has a affected person help program; households can inquire at dexcom.com.
The Backside Line
The FDA’s OTC clearance of the Dexcom Stelo CGM for youngsters as younger as 2 years represents a significant enlargement of entry to glucose monitoring expertise — significantly for households managing prediabetes or non-insulin-treated Kind 2 diabetes with out constant specialist entry. The machine is a monitoring device, not a therapy, and it isn’t acceptable for insulin-using youngsters.